October 7- EOD

Macro, macro, and more macro. That seems to be driving the market and without any significant biotech specific news that was the word of the day. As we get closer.

October 4- EOD

It green morning with biotechs taking part in the early rally and showing perhaps some minor strength but nothing earth shattering. Again it was a relatively quiet day on the.

October 3- EOD

Outside of a weak day in the macro which appears mainly related to macro issues, there does not seem to be a ton of news. Biotechs were obviously weak with.

October 2- EOD

Some macro weakness today but biotechs seemed to hold up fairly well. While most were red, it did not seem to be overdone to the downside. Plus, there were some.

October 1- EOD

It was a fairly busy day today in biotech land the sentiment certainly appears more positive. They participated in the market rally even though most were not big losers in.

September 30-EOD

There was certainly some interesting news and action today. The market was weak early but biotech was much more mixed than one would have expected. It is good to see.

September 30-EOD

There was certainly some interesting news and action today. The market was weak early but biotech was much more mixed than one would have expected. It is good to see.

September 30-EOD

There was certainly some interesting news and action today. The market was weak early but biotech was much more mixed than one would have expected. It is good to see.

September 27- EOD

Not a particularly news rich day but the sector seemed to continue its momentum from yesterday and seemed to outperform the general market with a lot of green on a.

September 26-EOD

It was an interesting news day and biotechs even participated in the market strength today, which has not happened in a little while. I would not call the biotech action.

September 25- EOD

A very interesting and odd day in the market today. Overall the market continued its weakness and biotechs were generally down. The market came back and it seemed to turn.

September 23rd EOD

It was a weak day in biotech (although it seemed to recover a little in the afternoon) and some of the biggest biotech bulls are turning cautious. Mike King of.

September 20- Daily Update – SRPT

Obviously the big news of the day was the failure of drisapersen in their phase III trial and what it means for etperlirsen and SRPT. While it is not clear.

September 19- EOD

It was a relatively quiet news day. I was not sure there would be much to write about and there is nothing really new or compelling. There are some quick.

September 18- EOD

It was Fed day today, so the market was very macro driven in terms of price action. The Bernank doubled down on easing, which was a good macro environment. That.

September 18- EOD

It was Fed day today, so the market was very macro driven in terms of price action. The Bernank doubled down on easing, which was a good macro environment. That.

September 18- EOD

It was Fed day today, so the market was very macro driven in terms of price action. The Bernank doubled down on easing, which was a good macro environment. That.

September 17- EOD

Not a lot of stock specific news but some interesting larger biotech developments. The market held up better than I thought given yesterday’s close and biotechs seemed like slight underperformers.

September 16- EOD

It was a strong day in the market but a weak day in biotech. That being said I think there was a definite pattern in that the large caps and.

September 16- EOD

It was a strong day in the market but a weak day in biotech. That being said I think there was a definite pattern in that the large caps and.

Browsing 20 / 1201 articles